Literature DB >> 3901368

Proteinases in inflammatory demyelinating disease.

C T Bever, J N Whitaker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3901368     DOI: 10.1007/bf00197298

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  112 in total

1.  Lysosomal enzymes in motor neurone disease and multiple sclerosis.

Authors:  C M Yates; H Wilson; D Davidson
Journal:  Clin Chim Acta       Date:  1973-09-14       Impact factor: 3.786

2.  Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.

Authors:  M L Cuzner; A N Davison; P Rudge
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

3.  The sequential limited degradation of bovine myelin basic protein by bovine brain cathepsin D.

Authors:  J N Whitaker; J M Seyer
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

4.  Loss of lysosomal neutral proteinase from leucocytes induced by the action of multiple sclerosis-specific brain antigens.

Authors:  S C Rastogi; J Clausen
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

5.  White matter proteins in multiple sclerosis.

Authors:  J Newcombe; M L Cuzner; M Röyttä; H Frey
Journal:  J Neurochem       Date:  1980-03       Impact factor: 5.372

6.  Myelin composition in acute and chronic multiple sclerosis in relation to cerebral lysosomal activity.

Authors:  M L Cuzner; R O Barnard; B J MacGregor; N J Borshell; A N Davison
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

7.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.

Authors:  W Cammer; B R Bloom; W T Norton; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

8.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

9.  Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.

Authors:  S Gordon; J C Unkeless; Z A Cohn
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

10.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  2 in total

1.  Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis.

Authors:  S J Huterer; W W Tourtellotte; J R Wherrett
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 2.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.